Green Tea’s Clot-Busting Power: Protecting Against cardiovascular diseases (CVD)

Understanding Platelet Activation and Aggregation

In Cardiovascular Disease (CVD), platelet activation and aggregation play a key role. Damaged blood vessels trigger rapid platelet response, forming plugs and potential clots that can block vessels.

Green Tea’s Inhibitory Moves:

Green tea catechins have shown promise in inhibiting platelet aggregation in various animal studies.

Unlocking Cellular Targets:

  • Studies suggest catechins may affect platelet activation by:
    • Interfering with the arachidonic acid pathway.
    • Inhibiting calcium increase in platelets.
    • Reducing thromboxane A2 (TXA2) production.
    • Blocking cyclooxygenase-1 (COX-1).

Human Platelet Protection:

  • In human platelet studies, EGCG demonstrated the ability to:
    • Inhibit platelet activation triggered by adenosine diphosphate (ADP).
    • Suppress p38 MAPK phosphorylation of heat shock protein 27 (HSP27), curbing the release of pro-thrombotic contents.

Green tea, with its catechins, emerges as a natural defender, hindering the risky dance of platelet aggregation. By targeting key cellular pathways, it holds potential in preventing vessel occlusion and enhancing cardiovascular health.

Reference: Wanda C. Reygaert. An Update on the Health Benefits of Green Tea. Beverages 2017, 3(1), 6

Other interesting articles:

Leave a Reply

Your email address will not be published. Required fields are marked *

Please reload

Please Wait